Towards a more cost-effective diabetes control in primary care: six-monthly monitoring compared with three-monthly monitoring in type 2 diabetes mellitus. The EFFIMODI (EFFIcient MOnitoring of DIabetes) trial.
Completed
- Conditions
- type 2 diabetes mellitusnon insulin dependent diabetes mellitus10018424
- Registration Number
- NL-OMON33609
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 2250
Inclusion Criteria
- People with type 2 diabetes mellitus;
- Aged 40-80 years;
- Treated by their general practitioner.
Exclusion Criteria
Contra-indications for less frequent than three-monthly monitoring:
- Duration of type 2 diabetes mellitus for less than one year;
- Insulin treatment;
- HbA1c >7.5%;
- Systolic blood pressure >145 mmHg;
- Total cholesterol >5.2 mmol/L.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Glycemic control, expressed as HbA1c%.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Blood pressure, body mass index, cholesterol, patients* quality of life and<br /><br>distress, satisfaction with care, costs.</p><br>